Related references
Note: Only part of the references are listed.Regulation of RANKL-Induced Osteoclastogenesis by TGF-β Through Molecular Interaction Between Smad3 and Traf6
Tetsuro Yasui et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Regulation of p53 Family Member Isoform ΔNp63α by the Nuclear Factor-κB Targeting Kinase IκB Kinase β
Aditi Chatterjee et al.
CANCER RESEARCH (2010)
SINGLE-MARKER IDENTIFICATION OF HEAD AND NECK SQUAMOUS CELL CARCINOMA CANCER STEM CELLS WITH ALDEHYDE DEHYDROGENASE
Matthew R. Clay et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2010)
TGF beta signaling in head and neck squamous cell carcinoma
R. A. White et al.
ONCOGENE (2010)
Attenuated Transforming Growth Factor β Signaling Promotes Nuclear Factor-κB Activation in Head and Neck Cancer
Jonah Cohen et al.
CANCER RESEARCH (2009)
Progressive Tumor Formation in Mice with Conditional Deletion of TGF-β Signaling in Head and Neck Epithelia Is Associated with Activation of the PI3K/Akt Pathway
Yansong Bian et al.
CANCER RESEARCH (2009)
The IκB kinase complex: master regulator of NF-κB signaling
Laura A. Solt et al.
IMMUNOLOGIC RESEARCH (2008)
A signal network involving coactivated NF-κB and STAT3 and altered p53 modulates BAX/BCL-XL expression and promotes cell survival of head and neck squamous cell carcinomas
Tin Lap Lee et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-β
Motozo Yamashita et al.
MOLECULAR CELL (2008)
The type I TGF-β receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner
Alessandro Sorrentino et al.
NATURE CELL BIOLOGY (2008)
Deficient TP53 expression, function, and cisplatin sensitivity are restored by quinacrine in head and neck cancer
Jay Friedman et al.
CLINICAL CANCER RESEARCH (2007)
Smad7 sensitizes tumor necrosis factor -: Induced apoptosis through the inhibition of antiapoptotic gene expression by suppressing activation of the nuclear factor-κB pathway
Suntaek Hong et al.
CANCER RESEARCH (2007)
Smad7 binds to the adaptors TAB2 and TAB3 to block recruitment of the kinase TAK1 to the adaptor TRAF2
Suntaek Hong et al.
NATURE IMMUNOLOGY (2007)
Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-κB activation and proliferation in human head and neck squamous cell carcinoma
D. G. Jackson-Bernitsas et al.
ONCOGENE (2007)
Nuclear factor-κ13 in development, prevention, and therapy of cancer
Carter Van Waes
CLINICAL CANCER RESEARCH (2007)
Genome-wide identification of novel expression signatures reveal distinct patterns and prevalence of binding motifs of p53, NF-kappaB and other signal transcription factors in head and neck squamous cell carcinoma
Bin Yan et al.
GENOME BIOLOGY (2007)
Loss of transforming growth factor-β type II receptor promotes metastatic head-and-neck squamous cell carcinoma
Shi-Long Lu et al.
GENES & DEVELOPMENT (2006)
Celastrol, a triterpene extracted from the Chinese Thunder of God Vine, is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice
Huanjie Yang et al.
CANCER RESEARCH (2006)
Overexpression of phosphorylated nuclear factor-kappa B in tonsillar squamous cell carcinoma and high-grade dysplasia is associated with poor prognosis
PL Zhang et al.
MODERN PATHOLOGY (2005)
Herbal medications commonly used in the practice of rheumatology: Mechanisms of action, efficacy, and side effects
AR Setty et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2005)
Signaling mechanism of TGF-βl in prevention of renal inflammation:: Role of Smad7
WS Wang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Beneficial effect of tripterine on systemic lupus erythematosus induced by active chromatin in BALB/c mice
H Li et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
Prostate stem cell antigen is overexpressed in prostate cancer metastases
JS Lam et al.
CLINICAL CANCER RESEARCH (2005)
Anti-inflammatory compounds of plant origin. Part II. Modulation of pro-inflammatory cytokines, chemokines and adhesion molecules
JB Calixto et al.
PLANTA MEDICA (2004)
Secreted transforming growth factor β2 activates NF-κB, blocks apoptosis, and is essential for the survival of some tumor cells
T Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
HER2/Neu- and TAK1-mediated up-regulation of the transforming growth factor β inhibitor Smad7 via the ETS protein ER81
SC Dowdy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Smad-dependent and Smad-independent pathways in TGF-β family signalling
R Derynck et al.
NATURE (2003)
Expression of TAK1, a mediator of TGF-β and BMP signaling, during mouse embryonic development
JL Jadrich et al.
GENE EXPRESSION PATTERNS (2003)
Transforming growth factor-β1 (TGF-β)-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-β-activated kinase 1 and mitogen-activated protein kinase kinase 3
S Edlund et al.
MOLECULAR BIOLOGY OF THE CELL (2003)
Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer
PM Siegel et al.
NATURE REVIEWS CANCER (2003)
Benefit of an extract of Tripterygium wilfordii Hook F in patients with rheumatoid arthritis -: A double-blind, placebo-controlled study
XL Tao et al.
ARTHRITIS AND RHEUMATISM (2002)
Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-κB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines
CC Bancroft et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Transforming growth factor-beta 1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism
NA Bhowmick et al.
MOLECULAR BIOLOGY OF THE CELL (2001)
TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway
G Takaesu et al.
MOLECULAR CELL (2000)
TAK1 mediates an activation signal from toll-like receptor(s) to nuclear factor-κB in lipopolysaccharide-stimulated macrophages
T Irie et al.
FEBS LETTERS (2000)
Share Paper
